
DU Knib 250mg Tablet
Marketer
Sayre Therapeutics Pvt Ltd
Salt Composition
Lapatinib (250mg)
Overview DU Knib 250mg Tablet
Knib 250mg tablets are indicated for breast cancer management. Their mechanism involves inhibiting or reducing the proliferation of cancerous cells. This medication is administered either solely or alongside other therapies in advanced breast cancer. Optimal absorption requires ingestion on an empty stomach, or one hour prior to, or two hours after, meals. Dosage and treatment length are personalized based on individual disease severity and therapeutic response. Strict adherence to the prescribed regimen is vital to minimize adverse effects. While benefits may not be immediately apparent (requiring weeks or months), discontinuation should only occur under physician guidance. Common side effects include nausea, headache, back pain, and respiratory distress. Severe diarrhea necessitates increased fluid intake or medical consultation. Regular blood pressure monitoring may be necessary. Report severe headaches, confusion, visual disturbances, nausea, or vomiting to your doctor immediately. Liver function assessments are typically conducted before, during, and after treatment. Prior to commencing treatment, disclose any liver or kidney ailments. Potential drug interactions necessitate informing your healthcare provider of all medications currently being used. This medication is contraindicated during pregnancy and lactation. Employing effective contraception is crucial for both partners throughout the treatment period to prevent conception.
Primary Ingredients of DU Knib 250mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of DU Knib 250mg Tablet
Malignant breast tumor
Major Benefits of DU Knib 250mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer DU Knib 250mg Tablet on an empty stomach.
Common Side effects of DU Knib 250mg Tablet:
- Abdominal pain
- Back pain
- Breathing problems
- Constipation
- Cough
- Diarrhea
- Fatigue
- Headache
- Hot flashes
- Increased bilirubin in the blood
- Insomnia (difficulty in sleeping)
- Joint pain
- Liver damage
- Loss of appetite
- Mucosal inflammation
- Nausea
- Pain in extremities
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weakness
- Weight gain
How to use DU Knib 250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer DU Knib 250mg Tablet on an empty stomach.
How DU Knib 250mg Tablet works:
DU Knib 250mg tablets are prescribed for cancer treatment. Their mechanism of action targets HER2 and EGFR receptors, proteins that trigger excessive cell growth. By binding to these receptors, the drug blocks the signaling pathways that drive cancer cell proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside DU Knib 250mg Tablet may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Employing DU Knib 250mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Lactation and DU Knib 250mg tablets are incompatible; the medication poses a potential toxicity risk to the nursing infant.
DrivingUNSAFE
Taking a DU Knib 250mg Tablet might impair your driving ability due to potential side effects.
KidneyCAUTION
Exercise caution when administering DU Knib 250mg Tablets to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician. Data regarding DU Knib 250mg Tablet use in such patients is limited. Dosage alteration is not advised for those with mild to moderate kidney disease.
LiverCAUTION
Caution is advised when administering 250mg DU Knib tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Data regarding the drug's use in patients exhibiting severe liver dysfunction are scarce.
What if you forget to take DU Knib 250mg Tablet :
Omit a DU Knib 250mg Tablet dose? Seek your physician's advice.
Facts to Know About DU Knib 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline Amine Derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Tyrosine kinase inhibitor drugs |
